Inhibiting the nuclear factor κB (NF‐κB) pathway activation can reduce inflammation, facilitate osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) [18, 19], and ultimately improve periodontitis [20]. The gene discussed is NFKB1; the disease is periodontitis.